Want to see AMS full AI Analyst Report?
Top Page
American Shared Hospital Services
(AMS)
Select Model
Select Model
Rating:53Neutral
Price Target:
$1.50
▲(2.74% Upside)
Action:Reiterated
Date:08/17/26
AMS scores in the low-to-mid range primarily due to still-weak profitability and historical volatility despite improved TTM cash generation and reduced leverage. Technicals are broadly neutral with only modest momentum and a weaker longer-term trend versus the 200-day average. Valuation provides limited support given the negative P/E and no dividend, while the earnings call showed improving operations and liquidity that are tempered by continued capital-structure and refinancing risk.
Positive Factors
Sustained Revenue Growth
Double-digit quarterly and first-half growth indicates improving demand and utilization across the treatment network. Sustained expansion in provider-site activity can support recurring contractual revenue if the company continues adding capacity and retaining hospital relationships.
Negative Factors
Persistent Unprofitability
Revenue growth has not yet translated into durable profitability, with low gross margin and negative operating and net income. Continued losses limit internally funded expansion, weaken equity returns, and leave execution dependent on cost control and improved site economics.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained Revenue Growth
Double-digit quarterly and first-half growth indicates improving demand and utilization across the treatment network. Sustained expansion in provider-site activity can support recurring contractual revenue if the company continues adding capacity and retaining hospital relationships.
Read all positive factors
American Shared Hospital Services (AMS) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$9.51M
Dividend YieldN/A
Average Volume (3M)78.93K
Price to Earnings (P/E)―
Beta (1Y)0.33
Revenue Growth3.97%
EPS Growth28.88%
CountryUS
Employees83
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)-0.25
Shares Outstanding6,650,000
10 Day Avg. Volume41,017
30 Day Avg. Volume78,931
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)0.58
Price to Sales (P/S)0.50
P/FCF Ratio-3.08
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.05
Revenue Forecast (FY)$29.95M
American Shared Hospital Services Business Overview & Revenue Model
Company Description
American Shared Hospital Services specializes in leasing advanced radiosurgery and radiation therapy equipment to healthcare providers. The company offers Gamma Knife stereotactic radiosurgery systems, a non-invasive technology used to treat condi...
How the Company Makes Money
AMS primarily makes money by structuring arrangements that enable hospitals and medical centers to offer advanced radiation-based cancer treatments using specialized equipment and associated clinical support. Revenue is generally earned through co...
American Shared Hospital Services Earnings Call Summary
Earnings Call Date:Aug 13, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Nov 18, 2026
Earnings Call Sentiment Positive
The call communicated clear operational progress: double‑digit revenue growth, strong expansion of direct patient services (≈+40% Q2), meaningful proton therapy growth (~+22%), international throughput gains after technology upgrades, and robust cash generation (operating cash flow $4.4M YTD; cash up >80% vs year‑end). These positives are tempered by near‑term balance sheet and earnings noise: a $909K receivable allowance, $285K legal costs, a YoY Q2 adjusted EBITDA decline (from $1.7M to $1.3M), and an amended loan with potential sale provisions and refinancing risk ( ~$15.5M due by June 2027). Overall, operational momentum and improved liquidity/supporting financing actions outweigh the balance‑sheet and one‑time challenges, though capital structure risk remains the primary area of concern.Positive Updates
Strong Top-Line Growth
Total revenue for Q2 2026 was approximately $8.4M, up 19.2% year‑over‑year. First half 2026 revenue was ~$15.5M, an increase of 17.7% versus the first half of 2025.
Negative Updates
Reported Net Loss Impacted by One‑Time Charges
Reported net loss widened in Q2 due primarily to $285K of legal and professional fees related to negotiating the third amendment to the credit agreement and a $909K increase in allowance for credit losses against Rhode Island receivables (through 05/31/2025). Management characterized these as largely independent of core operating trends.
Read all updates
Q2-2026 Updates
Positive
Negative
Strong Top-Line Growth
Total revenue for Q2 2026 was approximately $8.4M, up 19.2% year‑over‑year. First half 2026 revenue was ~$15.5M, an increase of 17.7% versus the first half of 2025.
Read all positive updates
Company Guidance
Management's guidance focused on three clear priorities—drive sustainable revenue growth by increasing utilization and expanding the installed base, convert that revenue into improved profitability and operating cash flow, and strengthen the balance sheet—supported by the quarter's metrics: Q2 revenue ~ $8.4M (+19.2% YoY) and H1 revenue > $15.5M (+17.7%); Direct Patient Services Q2 revenue ~ $4.9M (+~40%) and H1 ~ $8.9M (+35%); Proton beam revenue Q2 ~ $2.3M (+22%) and H1 ~ $4.3M; gross margin ~ $1.4M; adjusted EBITDA Q2 ~ $1.3M (YTD ~ $2.5M; prior-year Q2 ~$1.7M); operating cash flow of $4.4M in H1 and cash of ~ $6.8M at quarter end (up >80% since the start of the year from $3.7M at YE2025); offsetting items included a $909k allowance for credit losses and $285k of legal/professional costs, with post-quarter support from $2M of subordinated financing and a Fifth Third amendment extending loan maturity to 6/30/2027 on roughly $15.5M of outstanding debt (potentially ~$13.3M after adjustments) while management pursues refinancing or other strategic options.American Shared Hospital Services Financial Statement Overview
Summary
Income Statement
42
Neutral
Balance Sheet
63
Positive
Cash Flow
58
Neutral
| Breakdown | TTM | Mar 2026 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.41M | 28.08M | 28.34M | 21.32M | 19.75M | 17.63M |
| Gross Profit | 5.20M | 5.04M | 9.19M | 9.34M | 8.38M | 6.73M |
| EBITDA | 3.09M | 4.07M | 8.91M | 6.97M | 8.44M | 6.97M |
| Net Income | -1.77M | -1.55M | 2.19M | 610.00K | 1.33M | 194.00K |
Balance Sheet | ||||||
| Total Assets | 52.49M | 55.48M | 60.20M | 48.16M | 43.96M | 45.43M |
| Cash, Cash Equivalents and Short-Term Investments | 6.51M | 3.46M | 11.03M | 13.69M | 12.34M | 8.14M |
| Total Debt | 20.52M | 22.61M | 23.23M | 17.64M | 14.31M | 17.47M |
| Total Liabilities | 26.68M | 27.79M | 30.17M | 21.88M | 18.33M | 21.19M |
| Stockholders Equity | 23.11M | 24.03M | 25.18M | 22.62M | 21.63M | 19.89M |
Cash Flow | ||||||
| Free Cash Flow | 3.54M | -4.54M | -7.77M | -555.00K | 6.85M | 4.59M |
| Operating Cash Flow | 5.35M | 3.10M | 167.00K | 5.72M | 7.24M | 6.27M |
| Investing Cash Flow | -1.82M | -7.63M | -7.11M | -6.27M | -388.00K | -1.67M |
| Financing Cash Flow | -8.11M | -3.03M | 4.41M | 1.91M | -2.66M | -655.00K |
American Shared Hospital Services Technical Analysis
Negative
1.46
Price Trends
1.49
Negative
1.48
Negative
1.79
Negative
Market Momentum
>-0.01
Positive
47.02
Neutral
19.15
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AMS, the sentiment is Negative. The current price of 1.46 is below the 20-day moving average (MA) of 1.51, below the 50-day MA of 1.49, and below the 200-day MA of 1.79, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 47.02 is Neutral, neither overbought nor oversold. The STOCH value of 19.15 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AMS.
American Shared Hospital Services Risk Analysis
American Shared Hospital Services disclosed 25 risk factors in its most recent earnings report. American Shared Hospital Services reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
American Shared Hospital Services Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $7.01B | 26.03 | 27.15% | ― | 15.15% | 101.51% | |
64 Neutral | $1.59B | 20.45 | 5.21% | ― | 3.34% | -69.26% | |
53 Neutral | $9.51M | -5.82 | -6.38% | ― | 3.97% | 28.88% | |
53 Neutral | $21.62M | -0.04 | 5.73% | ― | 20.26% | 69.68% | |
52 Neutral | $1.83B | -20.22 | -5.21% | ― | 3.99% | 51.58% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
42 Neutral | $424.44M | -1.33 | 20.91% | ― | -5.25% | ― |
* Healthcare Sector Average
AMS
American Shared Hospital Services
1.47
-1.01
-40.73%
CYH
Community Health
2.97
0.25
9.19%
CCM
Concord Medical Services
4.95
-0.69
-12.23%
SGRY
Surgery Partners
14.05
-8.64
-38.08%
PACS
PACS Group Inc
43.94
32.28
276.84%
ARDT
Ardent Health Partners, Inc.
11.30
-1.23
-9.82%
American Shared Hospital Services Corporate Events
Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
American Shared Hospital Services Enters New Financing Agreements
Negative
Jul 28, 2026
On July 22, 2026, American Shared Hospital Services and certain subsidiaries entered a Third Amendment and Forbearance Agreement with Fifth Third Bank, addressing previously asserted events of default under a 2021 credit facility and securing a st...
Business Operations and StrategyExecutive/Board Changes
American Shared Hospital Services Names Interim Chief Financial Officer
Neutral
Jul 13, 2026
On July 7, 2026, American Shared Hospital Services announced that Chief Financial Officer Raymond S. Frech resigned for personal reasons, with the company stating his departure did not stem from any disagreement over accounting policies or practic...
Shareholder Meetings
American Shared Hospital Services Holds Annual Shareholder Meeting
Neutral
Jun 30, 2026
On June 24, 2026, American Shared Hospital Services convened its annual meeting of shareholders, reflecting routine corporate governance activities for the healthcare services provider. The gathering underscored ongoing engagement with investors a...
Financial DisclosuresPrivate Placements and FinancingRegulatory Filings and Compliance
American Shared Hospital Faces Multiple Loan Defaults, Liquidity Strain
Negative
Jun 4, 2026
On May 29, 2026, American Shared Hospital Services and affiliated borrowers received notice from Fifth Third Bank that multiple events of default had occurred under their April 9, 2021 credit agreement, including failure to meet minimum cash requi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.